181 related articles for article (PubMed ID: 28665713)
1. mRNA levels of circadian clock components Bmal1 and Per2 alter independently from dosing time-dependent efficacy of combination treatment with valsartan and amlodipine in spontaneously hypertensive rats.
Potucek P; Radik M; Doka G; Kralova E; Krenek P; Klimas J
Clin Exp Hypertens; 2017; 39(8):754-763. PubMed ID: 28665713
[TBL] [Abstract][Full Text] [Related]
2. Circadian gene expression of clock genes and plasminogen activator inhibitor-1 in heart and aorta of spontaneously hypertensive and Wistar-Kyoto rats.
Naito Y; Tsujino T; Kawasaki D; Okumura T; Morimoto S; Masai M; Sakoda T; Fujioka Y; Ohyanagi M; Iwasaki T
J Hypertens; 2003 Jun; 21(6):1107-15. PubMed ID: 12777947
[TBL] [Abstract][Full Text] [Related]
3. Valsartan chronotherapy reverts the non-dipper pattern and improves blood pressure control through mediation of circadian rhythms of the renin-angiotensin system in spontaneous hypertension rats.
Yang K; Wang Y; Ding Y; Cui H; Zhou D; Chen L; Ma Z; Wang W; Zhang W; Luan J
Chronobiol Int; 2019 Aug; 36(8):1058-1071. PubMed ID: 31096810
[No Abstract] [Full Text] [Related]
4. Chronotherapy with valsartan/amlodipine fixed combination: improved blood pressure control of essential hypertension with bedtime dosing.
Hermida RC; Ayala DE; Fontao MJ; Mojón A; Fernández JR
Chronobiol Int; 2010 Jul; 27(6):1287-303. PubMed ID: 20653455
[TBL] [Abstract][Full Text] [Related]
5. Evening versus morning dosing of antihypertensive drugs in hypertensive patients with sleep apnoea: a cross-over study.
Kasiakogias A; Tsioufis C; Thomopoulos C; Andrikou I; Aragiannis D; Dimitriadis K; Tsiachris D; Bilo G; Sideris S; Filis K; Parati G; Stefanadis C
J Hypertens; 2015 Feb; 33(2):393-400. PubMed ID: 25318654
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of morning and evening dosing of amlodipine/valsartan combination in hypertensive patients uncontrolled by 5 mg of amlodipine.
Asmar R; Gosse P; Queré S; Achouba A
Blood Press Monit; 2011 Apr; 16(2):80-6. PubMed ID: 21372694
[TBL] [Abstract][Full Text] [Related]
7. Amlodipine decreases fibrosis and cardiac hypertrophy in spontaneously hypertensive rats: persistent effects after withdrawal.
Sevilla MA; Voces F; Carrón R; Guerrero EI; Ardanaz N; San Román L; Arévalo MA; Montero MJ
Life Sci; 2004 Jul; 75(7):881-91. PubMed ID: 15183079
[TBL] [Abstract][Full Text] [Related]
8. Transient prehypertensive treatment in spontaneously hypertensive rats: a comparison of losartan and amlodipine regarding long-term blood pressure, cardiac and renal protection.
Peng F; Lin J; Lin L; Tang H
Int J Mol Med; 2012 Dec; 30(6):1376-86. PubMed ID: 23064712
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of telmisartan and valsartan as add-on agents for hypertensive patients with morning blood pressure insufficiently controlled by amlodipine monotherapy.
Yoshida H; Akasaka H; Saitoh S; Shimamoto K; Miura T;
Hypertens Res; 2014 Mar; 37(3):225-31. PubMed ID: 24108237
[TBL] [Abstract][Full Text] [Related]
10. The effect of fixed-dose combination of valsartan and amlodipine on nighttime blood pressure in patients with non-dipper hypertension.
Erdoğan D; İçli A; Aksoy F; Akçay S; Yücel H; Ersoy İ; Özaydın M
Turk Kardiyol Dern Ars; 2016 Jul; 44(5):404-13. PubMed ID: 27439926
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
12. Amlodipine and atorvastatin improved hypertensive cardiac hypertrophy through regulation of receptor activator of nuclear factor kappa B ligand/receptor activator of nuclear factor kappa B/osteoprotegerin system in spontaneous hypertension rats.
Lu J; Liu F; Liu D; Du H; Hao J; Yang X; Cui W
Exp Biol Med (Maywood); 2016 Jun; 241(11):1237-49. PubMed ID: 26908571
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the effect of time dependent dosing on pharmacokinetic and pharmacodynamics of amlodipine in normotensive and hypertensive human subjects.
Khodadoustan S; Nasri Ashrafi I; Vanaja Satheesh K; Kumar C; Hs S; S C
Clin Exp Hypertens; 2017; 39(6):520-526. PubMed ID: 28598202
[TBL] [Abstract][Full Text] [Related]
14. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
[TBL] [Abstract][Full Text] [Related]
15. Effects of Amlodipine and Valsartan on Blood Pressure Variability and Pulse Wave Velocity in Hypertensive Patients.
Shi R; Liu K; Shi D; Liu Q; Chen X
Am J Med Sci; 2017 Jan; 353(1):6-11. PubMed ID: 28104105
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of valsartan versus amlodipine on left ventricular mass and reactive oxygen species formation by monocytes in hypertensive patients with left ventricular hypertrophy.
Yasunari K; Maeda K; Watanabe T; Nakamura M; Yoshikawa J; Asada A
J Am Coll Cardiol; 2004 Jun; 43(11):2116-23. PubMed ID: 15172423
[TBL] [Abstract][Full Text] [Related]
17. Differential time effect profiles of amlodipine, as compared to valsartan, revealed by ambulatory blood pressure monitoring, self blood pressure measurements and dose omission protocol.
Radauceanu A; Boivin JM; Bernaud C; Fay R; Zannad F;
Fundam Clin Pharmacol; 2004 Aug; 18(4):483-91. PubMed ID: 15312156
[TBL] [Abstract][Full Text] [Related]
18. Fosinopril and valsartan intervention in gene expression of Klotho, MMP-9, TIMP-1, and PAI-1 in the kidney of spontaneously hypertensive rats.
Cheng X; Zhou Q; Lin S; Wu R
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Oct; 35(10):1048-56. PubMed ID: 21051829
[TBL] [Abstract][Full Text] [Related]
19. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
[TBL] [Abstract][Full Text] [Related]
20. Synergism of telmisartan and amlodipine on blood pressure reduction and cardiorenal protection in hypertensive rats.
Liu W; Wang W; Song SW; Gu XF; Ma XJ; Su FY; Zhang H; Liu AJ; Su DF
J Cardiovasc Pharmacol; 2011 Mar; 57(3):308-16. PubMed ID: 21266915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
